Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Market Closed
Updated:
May 14, 2024
Fusion Antibodies PLC
Total Current Liabilities
|
Fusion Antibodies PLC
Total Current Liabilities Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Total Current Liabilities
£554k
|
CAGR 3-Years
-10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Total Current Liabilities
£89.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Total Current Liabilities
£29.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Total Current Liabilities
£3.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Total Current Liabilities
£37.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Total Current Liabilities
£35.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
65%
|
CAGR 10-Years
36%
|
See Also
What is Fusion Antibodies PLC's Total Current Liabilities?
Total Current Liabilities
554k
GBP
554k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Total Current Liabilities amounts to 554k GBP.
What is Fusion Antibodies PLC's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
0%
0%
Over the last year, the Total Current Liabilities growth was -51%. The average annual Total Current Liabilities growth rates for Fusion Antibodies PLC have been -10% over the past three years .
You don't have any saved screeners yet
